Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA accepts for review NDA for intranasal ROX-888

Feb. 9, 2009

New orexin receptor antagonists imparted by GSK for sleep disorders

Feb. 9, 2009

Novel gamma-secretase inhibitors patented by Schering-Plough for treating Alzheimer's disease

Feb. 9, 2009

King offers new dosage strengths of Avinza for chronic pain

Feb. 6, 2009

New mGluR1 and mGluR5 receptor ligands discovered at Gedeon Richter

Feb. 6, 2009

Novel T-type calcium channel inhibitors discovered by Merck & Co. researchers

Feb. 5, 2009

GlaxoSmithKline develops quinoline NK3 receptor antagonists with enhanced CNS activity

Feb. 4, 2009

Corcept reports results from clinical study of Corlux and Risperdal in weight gain

Feb. 4, 2009

Laminin-111 a potential therapy for alpha7 integrin congenital myopathy

Feb. 4, 2009

PTC completes enrollment in pivotal PTC-124 muscular dystrophy trial

Feb. 4, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026